Back to STATE STREET CORP STATE STREET CORP

KRYSKRYS
11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in Krystal Biotech, Inc.

STATE STREET CORP holds 1.4M shares of KRYS (Krystal Biotech, Inc.), worth $502.2M as of 2026-Q2. The position was increased (+2.8% shares). KRYS represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$502.2M

Current Shares

1.4M

Total Value Change

+$348.7M

Total Shares Change

+113,661

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.4M
+2.8%
$502.2M0.0%$371.67
32
2026-Q1
Decreased
1.3M
-2.1%
$339.5M0.0%$263.80
0
2025-Q4
Decreased
1.3M
-3.8%
$330.9M0.0%$247.88
0
2025-Q3
Increased
1.4M
+3.0%
$246.4M0.0%$176.75
32
2025-Q2
Increased
1.4M
+10.5%
$186.3M0.0%$138.88
34
2025-Q1
Decreased
1.2M
-4.1%
$221.2M0.0%$183.92
0
2024-Q4
Decreased
1.3M
-12.0%
$200.4M0.0%$159.80
0
2024-Q3
Increased
1.5M
+9.0%
$264.5M0.0%$177.14
34
2024-Q2
Increased
1.3M
+41.1%
$244.8M0.0%$183.64
41
2024-Q1
Decreased
944,547
-23.7%
$168.1M0.0%$177.93
0
2023-Q4
New
1.2M
-
$153.5M0.0%$124.06
42

Other major holders of KRYS: FMR LLC, BlackRock, Inc., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used